RA PHARMACEUTICALS, INC. Proceeds from Issuance Initial Public Offering
RA PHARMACEUTICALS, INC. reported Proceeds from Issuance Initial Public Offering of $140.20 million for the 1-month period ending 2019-07-31, per its 10-Q filed 2019-08-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2019-08-07
- RA PHARMACEUTICALS, INC. proceeds from issuance initial public offering for fiscal 2016 was $98.01M.
| Period end | Proceeds from Issuance Initial Public Offering 1 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|
| 2019-07-31 | $140.20M 10-Q · filed 2019-08-07 | |
| 2016-12-31 | $98.01M 10-K · filed 2018-03-14 |